Shorepoint Capital Partners LLC Abbott Laboratories Transaction History

Shorepoint Capital Partners LLC

$426 Million
Q3 2024

A detailed history of Shorepoint Capital Partners LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Shorepoint Capital Partners LLC holds 6,146 shares of ABT stock, worth $768,434. This represents 0.16% of its overall portfolio holdings.

Number of Shares

6,146

Previous 6,395 3.89%

Holding current value

$768,434

Previous $664,000 5.42%

% of portfolio

0.16%

Previous 0.16%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $24,917 - $29,414	-249 Reduced 3.89%	6,146 $700,000
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $54,092 - $60,380	-537 Reduced 7.75%	6,395 $664,000
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $31,322 - $34,594	-286 Reduced 3.96%	6,932 $787,000
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $360,309 - $441,048	-3,995 Reduced 35.63%	7,218 $794,000
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $225,928 - $271,076	-2,365 Reduced 17.42%	11,213 $1.09 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $18,241 - $20,324	-181 Reduced 1.32%	13,578 $1.48 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $508,127 - $598,096	-5,246 Reduced 27.6%	13,759 $1.39 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $580,911 - $681,498	6,111 Added 47.39%	19,005 $2.09 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $15,481 - $17,924	160 Added 1.26%	12,894 $1.25 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $4,184 - $5,058	41 Added 0.32%	12,734 $1.38 Million
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $1,482 - $1,807	-13 Reduced 0.1%	12,693 $1.5 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $2,772 - $3,395	24 Added 0.19%	12,706 $1.79 Million
Q3 2021 Nov 05, 2021	BUY	$116.66 - $129.06 $24,498 - $27,102	210 Added 1.68%	12,682 $1.5 Million
Q1 2021 May 10, 2021	SELL	$108.84 - $128.23 $1.57 Million - $1.85 Million	-14,404 Reduced 53.59%	12,472 $1.5 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $43,470 - $47,369	-414 Reduced 1.52%	26,876 $2.94 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $188,595 - $229,034	-2,058 Reduced 7.01%	27,290 $2.97 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $490,507 - $627,788	-6,406 Reduced 17.92%	29,348 $2.68 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $18,406 - $26,914	293 Added 0.83%	35,754 $2.82 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $98,451 - $109,599	-1,254 Reduced 3.42%	35,461 $3.08 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $27,089 - $29,372	-331 Reduced 0.89%	36,715 $3.07 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $2,332 - $2,720	32 Added 0.09%	37,046 $3.12 Million
Q1 2019 Apr 12, 2019	BUY	$66.22 - $80.06 $2.45 Million - $2.96 Million	37,014 New	37,014 $2.96 Million

Others Institutions Holding ABT

# of Institutions

3,204

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $219B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shorepoint Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shorepoint Capital Partners LLC with notifications on news.

Account

Shorepoint Capital Partners LLC Abbott Laboratories Transaction History